Why The Polynovo Ltd (ASX: PNV) Share Price Is Up 12%

Shares in Polynovo Ltd (ASX: PNV) have rocketed out of a trading halt this morning by more than 12%. Here’s what you need to know.

You’re reading a free article on Rask. Join 4,000+ Australians who get our expert advice, tools, exclusive research and investment recommendations. Get your 30-day trial for $1! Learn more

Shares in Polynovo Ltd (ASX: PNV) have rocketed out of a trading halt this morning by more than 12%. Here’s what you need to know.

About Polynovo Ltd

PolyNovo is an Australian medical device company that designs, develops, and manufactures dermal regeneration solutions using its patented NovoSorb biodegradable polymer technology. 

Its current product is NovoSorb BTM (Biodegradable Temporising Matrix), a wound dressing intended for treatment of full-thickness wounds and burns where the dermal structure requires a split-thickness skin graft for final closure.

What’s Happened?

PolyNovo shares were placed in a trading halt minutes before market open this morning, pending an announcement.

This announcement came at around midday today and was in relation to what the company has dubbed its ‘Two Million Dollar Month’. Revenue from NovoSorb BTM sales, unaudited, for the month of December 2019 surpassed $2 million for the first time ever.

For comparison, the company’s first $1 million dollar month was announced in early May 2019. This gives some indication to the acceleration of sales in the US, Australia and New Zealand.

Commenting on this latest announcement, PolyNovo CEO Paul Brennan said, “We are pleased with the sales trend. However, as a word of caution sales will continue to be lumpy as new sales staff are added and new territories opened up and because of natural disasters such as fires and volcanoes.”

What Happens Next?

While this seems positive, it’s important to keep in mind that PolyNovo is a company currently valued by the market at over $1 billion. That compares to sales of $2 million a month. Obviously, investors are placing a lot of emphasis on the company’s potential future growth.

The PolyNovo share price was last trading 12% higher at $2.04.

Finance & Investing Courses

Want to take your knowledge to the next level? Try one of our free or premium courses in finance, budgeting or investing today.

Whether you’re starting your journey, want confidence in what you’re doing, or hope to push your skills to the next level, we’ve got you covered.

Browse your course and enrol today!

online pharmacy clonidine for sale no prescription pharmacy

CSL, Xero, ANZ... the ASX is beaten up

Right now, only brave investors are buying. Is ASX Reporting Season your KEY opportunity to act? Buy, or sell.

This coming Monday night, our two most experienced professional investors, Owen Rask and Leigh Gant, are hosting an exclusive and rare webinar on the what to watch this ASX reporting season. LIVE and free

With over 35 years of combined investing experience, join our Chief Investment Officer and Head of Content for our free Q&A.

We’ll be diving into results from CSL, Pro Medicus (ASX: PME), ANZ Bank and more. It’s absolutely free to join us. Take advantage of this volatility with our free playbook. Simply click here to view the topics.

A $50,000 per year passive income special report

Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.

How can Rask help you?

About Rask

Learn more about us, our your community and our mission.

Rask investing philosophy

Nearly 15 years later.
It's still a work in progress.

Online investment community

You won't find our investment community on Facebook or Reddit because it's secure, free and available now.

Join 250,000+ podcast listeners

250,000 investors tune into the Rask podcasts every month. Find out why.

Find a financial planner

Australia's financial experts. At your doorstep.

Free finance courses

35,000 students have enrolled in free Rask courses. We're on a mission to 100,000.

Subscribe to Rask's free investor newsletter

53,000 Australian investors subscribe to our Sunday newsletter... and love it! It's free.

$50 million invested

We manage almost $50 million on behalf of Aussies. Discover how you can invest with us.

Better investing starts here.

Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best  insights.

5%+ in passive income

Get Rask’s special investing report

With bond ETFs like ASX:IAF and the S&P 500 riding high, now could be one of the best times to start earning passive income from a portfolio of shares and ETFs.

In this free analyst report, our Chief Investment Officer, Owen Rask, names 10 ASX stocks and ETFs to watch.

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Subscribe to Rask's free investor newsletter

Kick off your week with our pick of podcasts, courses and investing resources to keep your finger on the Rask pulse!

Here you go: A $50,000 per year passive income special report

Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.

Simply enter your email address and we’ll send it to you. No tricks. Unsubscribe anytime.

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.